Scientific leadership of drug discovery projects Setup and drive scientific collaborations with academic teamsDrive target validation activitiesDesign of competitive strategy

Leading anti-APRIL BION-1301 to first clinical use in IgA Nephropathy.

Project Team Leader of a Multiple Myeloma program (preclinical and Phase 1)

• Leadership of the Immunology Department with focus on cancer immunotherapy, viral infections and autoimmunity.• Initiates and maintains relationships with strategic accounts. Serves as an advisory partner in translating customer needs into effective solutions. Following internal and external (market) developments and identifies commercial opportunities.• Controls on revenue growth by developing and maintaining a network of strategic accounts.• Manages collaboration with external partners, both for operational and innovative issues.• Develops the long-term strategic policy for the Department of Immunology and associated operational annual plans.• Translates the annual operating plan for the division into concrete goals and actions.• Connect to other areas of expertise and between disciplines. Conducted market analyzes and evaluates the results of their own area of ​​expertise and portfolio analyzes carried out.• Reporting to the general manager of Triskelion

Single point of contact for Phama and Biotech customers related to e.g. viral Infections, autoimmune-diseases, bacterial infections and cancer Immunotherapy.

Head of preclinical pharmacology (influenza monoclonal antibodies)

Project leader pharmacology (monocloncal antibodies, biosimilars and small molecules in oncology, autoimmune diseases and osteoporosis).

Project leader (monocloncal antibodies/ biosimilars in oncology and infectious diseases)

Project leader (small molecules, autoimmune diseases)